Infant and fetal hyperlipidemia can be caused by the passage of stimulant antibodies from the mother's TSH receptor from the placenta, causing tachycardia, accelerating bone growth, and delaying intrauterine growth. The gene discussed is TSHR; the disease is hyperlipidemia.